Cargando…

Direct oral anticoagulants in extremely obese patients: OK to use?

Detalles Bibliográficos
Autores principales:	Moll, Stephan, Crona, Daniel J., Martin, Karlyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462739/ https://www.ncbi.nlm.nih.gov/pubmed/31011697 http://dx.doi.org/10.1002/rth2.12178

Ejemplares similares

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Therapeutic Monitoring of Direct Oral Anticoagulants—Back to the Future?
por: Hu, Kai, et al.
Publicado: (2020)

Hematohepatology: The potential for direct oral anticoagulant “Inflation” in liver transplant candidates
por: Schaefer, Jordan K., et al.
Publicado: (2023)

Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?
por: Lijfering, Willem M., et al.
Publicado: (2018)

To learn or not to learn from real-world experience on direct oral anticoagulants in pediatric patients?
por: Streif, Werner
Publicado: (2023)

I'm OK, you're OK
por: Harris, Thomas A
Publicado: (2004)

Commentary: When a cardiac surgeon takes care of patients with Coronavirus Disease 2019: It’s gonna be ok!
por: Miceli, Antonio
Publicado: (2020)

What can we learn from real world studies on direct oral anticoagulants?
por: Coppens, M.
Publicado: (2017)

The ok boss
por: James, Muriel
Publicado: (1975)

The Use of Direct Oral Anticoagulants in the Management of Venous Thromboembolism in Patients With Obesity
por: Younis, Moustafa, et al.
Publicado: (2020)

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Fazili, Masarret, et al.
Publicado: (2019)

Acute Stroke Treatment in Patients Receiving Direct Oral Anticoagulants: Is it Time to Review the Guidelines?
por: Ojha, Pawan K., et al.
Publicado: (2023)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Efficacy and Safety of Direct Oral Anticoagulants for Atrial Fibrillation Across Body Mass Index Categories
por: Kaplan, Rachel M., et al.
Publicado: (2020)

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment
por: Groat, Danielle, et al.
Publicado: (2022)

Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis
por: Montiel, Francisco Sánchez, et al.
Publicado: (2017)

Is it Still Ok to be Ok? Mental Health Labels as a Campus Technology
por: Armstrong, Neil, et al.
Publicado: (2023)

Oral Anticoagulants and Renal Impairment: The Convoluting Dilemma
por: Serebruany, Victor
Publicado: (2016)

High-y OK
Publicado: (1977)

Operación Guatemala OK
por: Osegueda, Raúl
Publicado: (1955)

Ok nemi totlahtõl
Publicado: (2009)

Imok-youre ok
por: Harris, Thomas A.
Publicado: (1973)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Organisation of care for patients using direct oral anticoagulants
por: Gulpen, A. J. W., et al.
Publicado: (2020)

It's ok to listen to the gray voice
por: Garbarek, Jan, 1947-
Publicado: (1985)

Future ok Kaon Experiments
por: Ceccucci, Augusto
Publicado: (2007)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Direct Oral Anticoagulants in Patients with Extremely Low and High Body Weight—Pilot Study
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Transvenous lead extraction on continued oral anticoagulation
por: Burri, Haran
Publicado: (2021)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

Direct oral anticoagulation and severe obesity – One size fits all?
por: Fender, Anke C., et al.
Publicado: (2021)

It’s OK not to be OK: Shared reflections from two PhD parents in a time of pandemic
por: Abdellatif, Amal, et al.
Publicado: (2020)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
por: Duong, Eric, et al.
Publicado: (2023)

Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli
por: Lachant, Daniel J., et al.
Publicado: (2021)

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

AD OK for 2K AD
Publicado: (1999)

Talk: Discovering the "OK BOSS" in an Organization
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_63hp8p7g8t8jbr5iuq4c99tnd7